• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page
Reaction score
0

Profile posts Latest activity Postings About

  • There are no messages on Megan Finn's profile yet.
  • Loading…
  • Loading…
  • Loading…